A pediatric case of KMT2A-rearranged B-lymphoblastic lymphoma treated with high-risk therapy

References

• Meyer C, Burmeister T, Gröger D, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273–284. doi:10.1038/leu.2017.213
   PubMed Web of Science ®Google Scholar
• El Chaer F, Keng M, Ballen KK. MLL-Rearranged acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2020;15(2):83–89. doi:10.1007/s11899-020-00582-5
   PubMed Web of Science ®Google Scholar
• Bolouri H, Farrar JE, Triche T, Jr., et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018;24(1):103–112. doi:10.1038/nm.4439
   PubMed Web of Science ®Google Scholar
• Pollard JA, Guest E, Alonzo TA, et al. Gemtuzumab ozogamicin improves Event-Free survival and reduces relapse in pediatric KMT2A-Rearranged AML: results from the phase III children’s oncology group trial AAML0531. J Clin Oncol. 2021;39(28):3149–3160. doi:10.1200/JCO.20.03048
   PubMed Web of Science ®Google Scholar
• Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240–250. doi:10.1016/S0140-6736(07)61126-X
   PubMed Web of Science ®Google Scholar
• Brown P, Pieters R, Biondi A. How I treat infant leukemia. Blood. 2019;133(3):205–214. doi:10.1182/blood-2018-04-785980
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Cancer Stat Facts. https://seer.cancer.gov/statfacts/html/nhl.html. Accessed 14 Jun, 2021.
   Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
   PubMed Web of Science ®Google Scholar
• Knez V, Bao L, Carstens B, et al. Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood. Leuk Lymphoma. 2020;61(9):2129–2135. doi:10.1080/10428194.2020.1761970
   PubMed Web of Science ®Google Scholar
• Lin P, Jones D, Dorfman DM, et al. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol. 2000;24(11):1480–1490. doi:10.1097/00000478-200011000-00003
   PubMed Web of Science ®Google Scholar
• Mater DV, Goodman BK, Wang E, et al. MLL duplication in a pediatric patient with B-cell lymphoblastic lymphoma. J Pediatr Hematol Oncol. 2012;34(3):e120-123–e123. doi:10.1097/MPH.0b013e3182273b57
   Web of Science ®Google Scholar
• Temple WC, Mueller S, Hermiston ML, et al. Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults. Best Pract Res Clin Haematol. 2023;36(1):101449. doi:10.1016/j.beha.2023.101449
   PubMed Web of Science ®Google Scholar
• Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39–49. doi:10.1111/j.1365-2141.2005.05735.x
   PubMed Web of Science ®Google Scholar
• Chimenti S, Fink-Puches R, Peris K, et al. Cutaneous involvement in lymphoblastic lymphoma. J Cutan Pathol. 1999;26(8):379–385. doi:10.1111/j.1600-0560.1999.tb01861.x
   PubMed Web of Science ®Google Scholar
• Boccara O, Laloum-Grynberg E, Jeudy G, et al. Cutaneous B-cell lymphoblastic lymphoma in children: a rare diagnosis. J Am Acad Dermatol. 2012;66(1):51–57. doi:10.1016/j.jaad.2010.10.040
   PubMed Web of Science ®Google Scholar
• Kahwash SB, Qualman SJ. Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor B-cell lineage. Pediatr Dev Pathol. 2002;5(1):45–53. doi:10.1007/s10024-001-0104-4
   PubMed Web of Science ®Google Scholar
• Larish AM, Dolan M, Casey T, et al. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy. J Pediatr Hematol Oncol. 2015;37(4):e215-217–e217. doi:10.1097/MPH.0000000000000296
   Web of Science ®Google Scholar
• Schafernak KT, Williams JA, Clyde BI, et al. Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma. Cancer Genet. 2021;258-259:23–26. doi:10.1016/j.cancergen.2021.06.006
   PubMed Web of Science ®Google Scholar
• Jung HS, Lin F, Wolpaw A, et al. A novel KMT2A-ARHGEF12 fusion gene identified in a high-Grade B-cell lymphoma. Cancer Genet. 2020;246-247:41–43. doi:10.1016/j.cancergen.2020.08.003
   PubMed Web of Science ®Google Scholar
• Kato S, Kubota Y, Sekiguchi M, et al. KMT2A-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization. Pediatr Hematol Oncol. 2021;38(3):281–289. doi:10.1080/08880018.2020.1838013
   PubMed Web of Science ®Google Scholar
• Kemps PG, Cleven AHG, van Wezel T, et al. B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement. Am J Hematol. 2020;95(11):1427–1429. doi:10.1002/ajh.25801
   PubMed Web of Science ®Google Scholar
• Hiroki H, Yoshimi A, Kato K, et al. Primary cutaneous diffuse large B-cell lymphoma with KMT2A-MLLT3: an infantile case study. J Pediatr Hematol Oncol. 2019;41(8):657–658. doi:10.1097/MPH.0000000000001527
   PubMed Web of Science ®Google Scholar
• Gindin T, Murty V, Alobeid B, et al. MLL/KMT2A translocations in diffuse large B-cell lymphomas. Hematol Oncol. 2015;33(4):239–246. doi:10.1002/hon.2158
   PubMed Web of Science ®Google Scholar
• Au-Yeung RKH, Padilla LA, Zimmermann M, et al. Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma. Leukemia. 2023;37(2):488–491. doi:10.1038/s41375-022-01757-0
   PubMed Web of Science ®Google Scholar
• Agarwal A, Rastogi A, Talwar J, et al. Unilateral limb orthosis for maintenance of deformity correction following treatment of clubfoot with Ponseti technique: a systematic review. J Pediatr Orthop B. 2021.
   Web of Science ®Google Scholar